Gapping up In reaction to strong earnings/guidance: ELMD +43.2%, NEWL +9.1%, BBBY +5.5%, SCS +4.3%, MTN +3.2%
M&A news: STRZA +5.7% (Starz considering sale although Fox (FOXA) is not interested, according to reports), ACOR +3.9% (to acquire Civitas Therapeutics for $525 mln in cash) Select metals/mining stocks trading higher: BHP +1%, AG +1%, NEM +0.9%, X +0.8%
Other news: RITT +36.3% (seeing continued strength), MACK +25.9% (co and Baxter (BAX) enter into exclusive ex-U.S. licensing agreement to develop and commercialize novel cancer compound MM-398), LPCN +16.7% (co to host a conference call to discuss top-line results from its Study of Oral Androgen Replacement pivotal Phase 3 clinical study), GDOT +6.3% (co's GoBank Checking Account launches exclusively at Walmart (WMT) ), MTL +6.2% (cont vol surrounding spec of co filing for bankruptcy), IMUC +5.6% (expands cancer immunotherapy platform with antigen-specific T-cell technology licensed from Caltech), ZSPH +5.1% (announced positive top-line results from HARMONIZE (ZS004), a second Phase 3 clinical trial of ZS-9 in patients with Hyperkalemia), AVNR +2.8% (prices 18.2 mln shares of its common stock at $11.00 per share), PLUG +2.6% (cont strength following co's reaffirm yesterday), SNY +2.1% (collaborates on gene therapy for rare disease that causes childhood blindness), GPRO +2% (cont vol pre-mkt trade), SCTY +1.8% (announced launch of a $500 mln convertible senior notes offering), TOT +1.8% (co's Energy Ventures is investing in NexSteppe startup), ALCS +1.7% (MFP Partners liquidated stake in the company), MU +1.3% (in discussions with Advanced Semi (ASX) to setup IC packaging and testing unit, according to reports), BABA +1.1% (cont vol following IPO), YPF +1.1% (Kyle Bass reveals stake in Argentine energy company YPF on CNBC)
Analyst comments: SRPT +4.1% (initiated with a Outperform at Credit Suisse), RIO +1.5% (upgraded to Overweight from Equal-Weight at Morgan Stanley), WGBS +1.1% (initiated with a Buy at Brean Capital), GLMD +1.1% (target raised to $24 at MLV & Co), OXY +1.1% (added to US 1 List at BofA/Merrill), AWAY +1% (initiated with a Buy at Sun Trust Rbsn Humphrey), HCLP +1% (upgraded to Buy from Hold at Wunderlich), ALV +0.9% (initiated with a Outperform at Exane BNP Paribas)